BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25120035)

  • 1. Knowledge, acceptability and personal attitude toward pre-implantation 1 genetic testing (PGT) and pre-natal diagnosis (PND) for females carrying BRCA pathogenic variant according to fertility preservation experience.
    Dervin T; Ranisavjevic N; Laot L; Mayeur A; Duperier C; Steffann J; Borghese R; Stoppa-Lyonnet D; Frydman N; Benachi A; Sonigo C; Grynberg M
    J Assist Reprod Genet; 2023 Jun; 40(6):1381-1390. PubMed ID: 37154838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility Preservation in BRCA1/2 Germline Mutation Carriers: An Overview.
    Silvestris E; Cormio G; Loizzi V; Corrado G; Arezzo F; Petracca EA
    Life (Basel); 2024 May; 14(5):. PubMed ID: 38792636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic bilateral Salpingo-oophorectomy and eventual development of endometrial cancer: Two individual case reports.
    Halassy S; Au K; Malviya V; Mullings-Britton J
    Case Rep Womens Health; 2020 Apr; 26():e00195. PubMed ID: 32257831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance and satisfaction with BRCA surveillance in specialized clinics versus community follow-up.
    Vortman R; Echar M; Singer A; Sagi-Dain L
    Eur J Cancer Prev; 2024 Jun; ():. PubMed ID: 38870036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providers' perspectives on the reproductive decision-making of BRCA-positive women.
    Dason ES; Drost L; Greenblatt EM; Scheer AS; Han J; Sobel M; Allen L; Jacobson M; Doshi T; Wolff E; McMahon E; Jones CA
    BMC Womens Health; 2022 Dec; 22(1):506. PubMed ID: 36482357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision Aids for Preventive Treatment Alternatives for
    Krassuski LM; Kautz-Freimuth S; Vennedey V; Rhiem K; Schmutzler RK; Stock S
    Geburtshilfe Frauenheilkd; 2021 Jun; 81(6):679-698. PubMed ID: 34168381
    [No Abstract]   [Full Text] [Related]  

  • 7. Reproductive Decision-Making in Women with BRCA1/2 Mutations.
    Chan JL; Johnson LNC; Sammel MD; DiGiovanni L; Voong C; Domchek SM; Gracia CR
    J Genet Couns; 2017 Jun; 26(3):594-603. PubMed ID: 27796678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility preservation in BRCA mutation carriers.
    Revelli A; Salvagno F; Delle Piane L; Casano S; Evangelista F; Pittatore G; Razzano A; Marchino GL; Gennarelli G; Benedetto C
    Minerva Ginecol; 2016 Oct; 68(5):587-601. PubMed ID: 26997146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of risk-reducing salpingo-oophorectomy in women with BRCA-1 and BRCA-2 mutations.
    Olopade OI; Artioli G
    Breast J; 2004; 10 Suppl 1():S5-9. PubMed ID: 14984481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of BRCA mutation carriers' knowledge about the clinical impact of prophylactic-oophorectomy and views on fertility consultation: a single-center pilot study.
    Kim J; Skrzynia C; Mersereau JE
    J Genet Couns; 2015 Feb; 24(1):149-57. PubMed ID: 25120035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy.
    Campfield Bonadies D; Moyer A; Matloff ET
    Fam Cancer; 2011 Mar; 10(1):79-85. PubMed ID: 20852945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.
    Madalinska JB; van Beurden M; Bleiker EM; Valdimarsdottir HB; Lubsen-Brandsma L; Massuger LF; Mourits MJ; Gaarenstroom KN; van Dorst EB; van der Putten H; Boonstra H; Aaronson NK
    J Clin Oncol; 2007 Jan; 25(3):301-7. PubMed ID: 17235045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of occult ovarian neoplasia and cancer in BRCA1/2 mutation carriers after the bilateral prophylactic salpingo-oophorectomy (PBSO): A single-center prospective study.
    Rudaitis V; Mikliusas V; Januska G; Jukna P; Mickys U; Janavicius R
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():26-31. PubMed ID: 32059136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
    Peccatori FA; Mangili G; Bergamini A; Filippi F; Martinelli F; Ferrari F; Noli S; Rabaiotti E; Candiani M; Somigliana E
    Hum Reprod; 2018 Feb; 33(2):181-187. PubMed ID: 29207007
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.